Last reviewed · How we verify

ZENTEL and Vitamin A Soft Capsules — Competitive Intelligence Brief

ZENTEL and Vitamin A Soft Capsules (ZENTEL and Vitamin A Soft Capsules) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anthelmintic + Vitamin supplement. Area: Infectious Disease / Parasitology.

marketed Anthelmintic + Vitamin supplement β-tubulin (albendazole component) Infectious Disease / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

ZENTEL and Vitamin A Soft Capsules (ZENTEL and Vitamin A Soft Capsules) — Chengdu Maternal and Children's Health Care Hospital. ZENTEL (albendazole) is an anthelmintic that inhibits microtubule polymerization in parasitic worms, while Vitamin A supports immune function and mucosal health.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ZENTEL and Vitamin A Soft Capsules TARGET ZENTEL and Vitamin A Soft Capsules Chengdu Maternal and Children's Health Care Hospital marketed Anthelmintic + Vitamin supplement β-tubulin (albendazole component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anthelmintic + Vitamin supplement class)

  1. Chengdu Maternal and Children's Health Care Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ZENTEL and Vitamin A Soft Capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/zentel-and-vitamin-a-soft-capsules. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: